| http://www.w3.org/ns/prov#value | - Some coagulation factors work to inhibit clot formation; these include antithrombin and the vitamin K-dependent proteins C and S.3,7-9 Patients who develop VTE are often treated with anticoagulants such as low-molecular-weight heparin (LMWH), unfractionated heparin (UFH), fondaparinux (Arixtra, generic), or warfarin (Coumadin, Jantoven, generic
|
